In the news, making news.
The latest from Teal Health — product, partnerships, research, and regulatory milestones — and where our work is showing up in the press.
As featured in
Making news in women’s preventive health
Featured
Teal Health Raises $22 Million Series A to Expand Access to the Most Accurate FDA-Authorized At-Home HPV Cervical Cancer Screening
Round Led by .406 Ventures Fuels Teal Health’s Next Phase of Growth, Expanding Payor, Health System, Employer and Provider Partnerships Ahead of Broad Insurance Coverage in 2027.
Following FDA Announcement, Teal Health’s Teal Wand™ for At-Home Cervical Cancer Screening is Now Available, Starting in California
The company, which has a waitlist of more than 32,000, is now available in California, with plans to expand into more states and be national before the end of 2026.
Teal Health Announces Publication of SELF-CERV Study Results in JAMA Network Open Following FDA Approval of Teal Wand™ for At-Home HPV Screening
Following its recent FDA approval, Teal Health® announced the publication of its multi-center pivotal SELF-CERV study in JAMA Network Open.
FDA Approves Teal Health’s Teal Wand™—The First and Only At-Home Self-Collection Device for Cervical Cancer Screening, Introducing a Comfortable Alternative to In-Person Screening
Women can now collect their own sample from the privacy of home, no speculum required, and mail it to a certified lab to be tested on the same test as the doctor’s office, with the same accuracy.